178 related articles for article (PubMed ID: 21422202)
1. Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.
Perez F; Pultz MJ; Endimiani A; Bonomo RA; Donskey CJ
Antimicrob Agents Chemother; 2011 Jun; 55(6):2585-9. PubMed ID: 21422202
[TBL] [Abstract][Full Text] [Related]
2. Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.
Hoyen CK; Pultz NJ; Paterson DL; Aron DC; Donskey CJ
Antimicrob Agents Chemother; 2003 Nov; 47(11):3610-2. PubMed ID: 14576127
[TBL] [Abstract][Full Text] [Related]
3. Effect of Fidaxomicin versus Vancomycin on Susceptibility to Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
Antimicrob Agents Chemother; 2016 Jul; 60(7):3988-93. PubMed ID: 27090175
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization.
Sbrana F; Malacarne P; Bassetti M; Tascini C; Vegnuti L; Della Siega P; Ripoli A; Ansaldi F; Menichetti F
Minerva Anestesiol; 2016 Jun; 82(6):635-40. PubMed ID: 26745619
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae colonization in neonates].
Ma MS; Wang DH; Sun XJ; Li ZH; Wang C
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Oct; 16(10):970-4. PubMed ID: 25344173
[TBL] [Abstract][Full Text] [Related]
6. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
7. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.
Endimiani A; Depasquale JM; Forero S; Perez F; Hujer AM; Roberts-Pollack D; Fiorella PD; Pickens N; Kitchel B; Casiano-Colón AE; Tenover FC; Bonomo RA
J Antimicrob Chemother; 2009 Nov; 64(5):1102-10. PubMed ID: 19740911
[TBL] [Abstract][Full Text] [Related]
8. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
Antochevis LC; Magagnin CM; Nunes AG; Goulart TM; Martins AS; Cayô R; Gales AC; Barth AL; Zavascki AP
J Glob Antimicrob Resist; 2018 Dec; 15():173-177. PubMed ID: 30071353
[TBL] [Abstract][Full Text] [Related]
9. Synergy Testing by E-Test and Microdilution Checkerboard for Fosfomycin Combined with Tigecycline against KPC-Producing Klebsiella pneumoniae.
Huang L; Wang M; Sun L
Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850708
[TBL] [Abstract][Full Text] [Related]
10.
Lin L; Xiao X; Wang X; Xia M; Liu S
Microb Drug Resist; 2020 Feb; 26(2):94-99. PubMed ID: 31433255
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
Elemam A; Rahimian J; Doymaz M
J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
[TBL] [Abstract][Full Text] [Related]
12. An animal model of limitation of gut colonization by carbapenemase-producing Klebsiella pneumoniae using rifaximin.
Xenofontos E; Renieris G; Kalogridi M; Droggiti DE; Synodinou K; Damoraki G; Koufargyris P; Sabracos L; Giamarellos-Bourboulis EJ
Sci Rep; 2022 Mar; 12(1):3789. PubMed ID: 35260705
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
14. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience.
Lübbert C; Faucheux S; Becker-Rux D; Laudi S; Dürrbeck A; Busch T; Gastmeier P; Eckmanns T; Rodloff AC; Kaisers UX
Int J Antimicrob Agents; 2013 Dec; 42(6):565-70. PubMed ID: 24100228
[TBL] [Abstract][Full Text] [Related]
15. Effect of Surotomycin, a Novel Cyclic Lipopeptide Antibiotic, on Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3333-9. PubMed ID: 26976870
[TBL] [Abstract][Full Text] [Related]
16. Oral gentamicin gut decontamination for prevention of KPC-producing Klebsiella pneumoniae infections: relevance of concomitant systemic antibiotic therapy.
Tascini C; Sbrana F; Flammini S; Tagliaferri E; Arena F; Leonildi A; Ciullo I; Amadori F; Di Paolo A; Ripoli A; Lewis R; Rossolini GM; Menichetti F;
Antimicrob Agents Chemother; 2014; 58(4):1972-6. PubMed ID: 24419337
[TBL] [Abstract][Full Text] [Related]
17. Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients.
Cano Á; Gutiérrez-Gutiérrez B; Machuca I; Torre-Giménez J; Gracia-Ahufinger I; Natera AM; Pérez-Nadales E; Castón JJ; Rodríguez-Baño J; Martínez-Martínez L; Torre-Cisneros J
Microbiol Spectr; 2022 Apr; 10(2):e0197021. PubMed ID: 35323035
[TBL] [Abstract][Full Text] [Related]
18. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany.
Lübbert C; Lippmann N; Busch T; Kaisers UX; Ducomble T; Eckmanns T; Rodloff AC
Am J Infect Control; 2014 Apr; 42(4):376-80. PubMed ID: 24679563
[TBL] [Abstract][Full Text] [Related]
19. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.
Orsi GB; Bencardino A; Vena A; Carattoli A; Venditti C; Falcone M; Giordano A; Venditti M
Infection; 2013 Feb; 41(1):61-7. PubMed ID: 23070604
[TBL] [Abstract][Full Text] [Related]
20. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.
Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
Infect Control Hosp Epidemiol; 2004 May; 25(5):373-9. PubMed ID: 15188841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
